Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg".
Alembic Pharmaceuticals Limited Press Release Jun 11 2026
Earlier from Alembic Pharmaceuticals
- Press Release Jun 05 2026
- Press Release May 22 2026
- Press Release May 15 2026
- Press Release May 14 2026